Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001600620-24-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | AUPH | Habig Scott Michael | Chief Commercial Off | S - Sale | $5.48 | -15.9K | 492.4K | -3% | -$87.0K | |
| 2024-02-22 | 2024-02-20 | AUPH | Habig Scott Michael | Chief Commercial Off | A - Grant | $0.00 | +195.5K | 508.2K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | S | D | 15,867 | $5.48 | 492,364 | D | — | — | (F2) Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant. |
| 2 | Common | Common Stock | 2024-02-20 | A | A | 195,512 | $0.00 | 508,231 | D | — | — | (F1) Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date. |